SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Grace Therapeutics, Inc. (GRCE) News

Track canonical SquawkNews coverage tagged to GRCE, Grace Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol GRCE Asset equity Sector Markets 90 days 7 Last 2.14 Updated Sep 03, 2026, 12:07 PM UTC Open live news feed
L Grace Therapeutics to participate in H.C. Wainright global investment conference Grace Therapeutics, Inc. (NASDAQ:GRCE) said it will participate in the H.C. Wainright 28th Annual Global Investment Conference. EQUITY | Sep 03, 2026, 12:07 PM UTC L Grace Therapeutics to participate in H.C. Wainright conference Grace Therapeutics (GRCE) will participate in the H.C. Wainright 28th Annual Global Investment Conference. EQUITY | Sep 03, 2026, 12:01 PM UTC L NBIS closes $5.75 billion private convertible note offering NBIS closes a private offering of convertible senior notes with aggregate gross proceeds of approximately $5.75 billion, while multiple other companies file shelf and registration statements. EQUITY | Aug 25, 2026, 09:46 AM UTC L GRCE files Form S-3 for up to 4,761,904 shares GRCE files a Form S-3 registration statement for up to 4,761,904 shares of common stock. REGULATION | Aug 24, 2026, 08:10 PM UTC L Grace Therapeutics reports first-quarter 2027 financial results Grace Therapeutics announces first-quarter 2027 financial results and provides a business update. EARNINGS | Aug 13, 2026, 12:01 PM UTC H Grace Therapeutics Announces $10 Million Private Placement Grace Therapeutics raises $10 million EQUITY | Aug 05, 2026, 01:01 AM UTC L Grace Therapeutics receives Type A meeting minutes from FDA Grace Therapeutics... EQUITY | Jul 28, 2026, 11:12 AM UTC L 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Can Fite Biopharma (AMEX: CANF ) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million. Atlantic International (NASDAQ: ATLN ) shares rose 17 EQUITY | Jul 01, 2026, 12:05 PM UTC